Cellosaurus logo
expasy logo

Cellosaurus IMR-32rMEL500 (CVCL_RR71)

[Text version]
Cell line name IMR-32rMEL500
Accession CVCL_RR71
Resource Identification Initiative To cite this cell line use: IMR-32rMEL500 (RRID:CVCL_RR71)
Comments Part of: Resistant Cancer Cell Line (RCCL) collection.
Population: Caucasian.
Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
Disease Neuroblastoma (NCIt: C3270)
Neuroblastoma (ORDO: Orphanet_635)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0346 (IMR-32)
Sex of cell Male
Age at sampling 1Y1M
Category Cancer cell line
STR profile Source(s): PubMed=31581737

Markers:
AmelogeninX,Y
CSF1PO11,12
D2S133823,24
D3S135816
D5S81811,12
D7S8209,10
D8S117913
D13S3179
D16S5398
D18S5112,15
D19S43314,15
D21S1130,31
FGA21,24
Penta D11,12
Penta E7,15
TH017,9.3
TPOX11
vWA15

Run an STR similarity search on this cell line
Web pages https://www.wass-michaelislab.org/rccl.php
Publications

PubMed=24466371; DOI=10.1593/tlo.13544; PMCID=PMC3890703
Loschmann N., Michaelis M., Rothweiler F., Zehner R., Cinatl J., Voges Y., Sharifi M., Riecken K., Meyer J., von Deimling A., Fichtner I., Ghafourian T., Westermann F., Cinatl J. Jr.
Testing of SNS-032 in a panel of human neuroblastoma cell lines with acquired resistance to a broad range of drugs.
Transl. Oncol. 6:685-696(2013)

PubMed=31581737; DOI=10.3390/cells8101194; PMCID=PMC6830094
Povey J.F., Saintas E., Aderemi A.V., Rothweiler F., Zehner R., Dirks W.G., Cinatl J. Jr., Racher A.J., Wass M.N., Smales C.M., Michaelis M.
Intact-cell MALDI-ToF mass spectrometry for the authentication of drug-adapted cancer cell lines.
Cells 8:1194.1-1194.12(2019)

Cross-references
Encyclopedic resources Wikidata; Q54897637
Entry history
Entry creation05-Mar-2018
Last entry update19-Dec-2024
Version number8